High Molecular Weight Derivatives of Human Fibrinogen Produced by Plasmin
Open Access
- 1 April 1969
- journal article
- Published by Elsevier
- Vol. 244 (8), 2120-2124
- https://doi.org/10.1016/s0021-9258(18)94374-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- New Anticoagulant from Lysed FibrinogenBritish Journal of Haematology, 1967
- Polymorphism in fibrinogen aggregatesJournal of Molecular Biology, 1966
- Stable Complex of Fibrinogen and FibrinScience, 1966
- THE ANTICOAGULANT AND ANTILYMPHOMA PROPERTIES OF ARSENIC AZOPROTEINSThe Journal of Experimental Medicine, 1964
- Anticoagulant Activity of Digest Products of Fibrinogen by PlasminThe Tohoku Journal of Experimental Medicine, 1964
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. II. THE SIGNIFICANCE, MECHANISM AND CONSEQUENCES OF DEFECTIVE FIBRIN POLYMERIZATION*Journal of Clinical Investigation, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. III. DEMONSTRATION OF ABNORMAL CLOT STRUCTURE BY ELECTRON MICROSCOPY*Journal of Clinical Investigation, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. I. THE SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS*Journal of Clinical Investigation, 1962
- THE CARBOHYDRATE OF γ-GLOBULIN AND MYELOMA PROTEINSThe Journal of Experimental Medicine, 1956
- BIOCHEMICAL STUDIES ON THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCIThe Journal of Experimental Medicine, 1934